Isolation, Characterization, and Immunogenicity of Mycoplasma pneumoniae Membranes

J D Pollack1, N L Somerson, L B Senterfit

  • 1Departments of Medical Microbiology and Pediatrics, Ohio State University, Children's Hospital, Columbus, Ohio 43205.

Infection and Immunity
|September 1, 1970
PubMed

Insights

This study characterizes the membrane and soluble fractions of Mycoplasma species, identifying key components and their locations. It reveals specific immunogens within Mycoplasma pneumoniae membranes responsible for metabolic-inhibiting and complement-fixing antibodies.

Area of Science:

  • Microbiology
  • Cell Biology
  • Immunology

Background:

  • Mycoplasma species are cell-wall-less bacteria with unique membrane compositions.
  • Understanding their cellular fractions is crucial for comprehending their biology and pathogenicity.

Purpose of the Study:

  • To analyze the biochemical composition and enzymatic activities of membrane and soluble fractions from Mycoplasma pneumoniae, M. pulmonis, and M. laidlawii B.
  • To identify and characterize immunogenic components within these fractions, particularly those of Mycoplasma pneumoniae.

Main Methods:

  • Hypotonic lysis was used to prepare membrane and soluble cellular fractions.
  • Biochemical analysis determined protein, lipid, carbohydrate, and RNA content.
  • Enzymatic activities (NADH(2) and NADPH(2) oxidase) were localized.
  • Lipid labeling studies incorporated radioactive precursors.
  • Immunodiffusion and complement fixation assays identified antigens and immunogens.

Main Results:

  • Mycoplasma pneumoniae and M. laidlawii B membranes are rich in lipids and proteins.
  • NADH(2) and NADPH(2) oxidase activities were found in different cellular fractions depending on the species.
  • Lipids of M. pneumoniae incorporated various fatty acids and sterols, with palmitic acid found in neutral lipid, glycolipid, and phosphatide fractions.
  • Three reactive antigens were detected, with two localized in the membrane, one possibly lipid-containing.
  • Both membrane and soluble fractions of M. pneumoniae were immunogenic, with membrane components eliciting metabolic-inhibiting and complement-fixing antibodies.

Conclusions:

  • The study delineates the distinct biochemical and antigenic profiles of Mycoplasma cellular fractions.
  • Membrane-associated components of Mycoplasma pneumoniae are significant immunogens, capable of inducing antibodies that interfere with cellular metabolism and activate complement.
  • These findings contribute to understanding Mycoplasma-host interactions and potential vaccine development.